Patent · US Active

System and method for screening and assessing agents for tumor immunotherapy

US11965875B2 · kind B2 · utility

0Cited by
0References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 18, 2021
Grant dateApr 23, 2024
Priority date
Expiry dateMay 17, 2042

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N33/5052
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present application relates to a system and a method for effectively screening and assessing agents for tumor immunotherapy, which includes assessment for the effects of target cells, non-target cells, and tumor infiltration. The system and method of the present application can be used to comprehensively and systematically assess the effectiveness and safety of the agent against tumor immune cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.